Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, ...

Researchers from Bar-Ilan University and Haifa University have unveiled a new theory of interpersonal synchrony that ...

Good evening, and welcome to Dyadic International Q3 2024 Conference Call. Currently, all participants are in a listen-only ...

Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology ...

Dyadic International has secured a $3 million grant from the Bill & Melinda Gates Foundation to develop cost-effectiv ...

Dyadic international was awarded a $3 million grant from the Bill & Melinda Gates Foundation to fund the development of ...

JUPITER, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale ...

总之，Dyadic International 2024年第三季度业绩电话会议揭示了公司财务状况强劲，在产品开发和商业化方面取得重大进展。公司的战略合作伙伴关系以及对生物技术板块高增长领域的关注，使其为持续成功奠定了良好基础。 Dyadic ...

Dyadic International (DYAI) announced that it has been awarded a $3M grant from the Gates Foundation for the cell line development of monoclonal antibodies targeting respiratory syncytial virus and ...

“We believe our third quarter achievements underscore Dyadic’s commitment to leveraging our proprietary Dapibus™ and C1 microbial protein production platforms to drive immediate and ...

Investor Conference call at 5:00 p.m. ET today. JUPITER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic”, "we”, "us”, "our”, or the "Company”) (NASDAQ: DYAI), a ...